Venture capital
Presight Capital
Venture investor whose listed holdings range from antibody and drug discovery to neurotechnology, heart disease diagnostics, fusion power, industrial robots and functional beverages.
Investment activity
Round-by-round activity is part of PRO
Key signal this week
Is Presight Capital right for your round?
Key stats
Fund cycle Public record
Fund vehicles on public registers (SEC adviser filings). Values are the gross assets each filing reports, not fund sizes.
Latest investments
BetaRounds Presight Capital joined, from press and the firm’s own posts.
1 round in the last 12 months
Round sizes, Presight Capital’s role and who invested alongside.
Notable portfolio
Portfolio and exits
Every company Presight Capital backed and how the exits played out.
Where the money goes
Share of companies at first investment, from the rounds we track.
Investment team
Where to meet Presight Capital
Events where Presight Capital’s team spoke or showed up, from event programmes, press and the firm’s own posts.
Signals
Register and fund filings are free. Website, team and portfolio changes we pick up are PRO.
Founders also look at
Frequently asked questions
Presight Capital is based in the United States.
8 fund vehicles are on public registers (SEC adviser filings), including APEIRON PRESIGHT CAPITAL FUND II, L.P., PRESIGHT PEPTILOGICS CO-INVEST FUND, L.P. and PRESIGHT RV CO-INVEST FUND, L.P.
Presight Capital lists 10 portfolio companies on its website, including AbCellera, Alloy Therapeutics, AtaiBeckley, Blackrock Neurotech and Cleerly.
Firms whose websites list some of the same companies include DCVC, AAF and AMR Action Fund.
Know before Presight Capital’s next round is announced.
PRO tracks Presight Capital’s filings, hires and portfolio changes the day they land, alongside 3,869 other firms.